- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/21 - Interferons
Patent holdings for IPC class A61K 38/21
Total number of patents in this class: 2309
10-year publication summary
|
172
|
177
|
151
|
169
|
230
|
175
|
168
|
105
|
106
|
83
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20868 |
36 |
| Iovance Biotherapeutics, Inc. | 411 |
32 |
| Centre National de La Recherche Scientifique | 11092 |
24 |
| Modernatx, Inc. | 1283 |
21 |
| Bristol-myers Squibb Company | 4757 |
20 |
| Gilead Sciences, Inc. | 2243 |
20 |
| Biogen MA Inc. | 942 |
19 |
| ellennbe GmbH | 25 |
19 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3325 |
18 |
| Vib VZW | 912 |
18 |
| Universiteit Gent | 1414 |
17 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3339 |
17 |
| Abion Inc. | 71 |
16 |
| Toray Industries, Inc. | 7145 |
15 |
| Enanta Pharmaceuticals, Inc. | 426 |
15 |
| IBC Pharmaceuticals, Inc. | 47 |
15 |
| PharmaEssentia Corp. | 80 |
15 |
| Orionis Biosciences Inc. | 112 |
15 |
| Orionis Biosciences BV | 82 |
15 |
| ILC Therapeutics Ltd | 23 |
14 |
| Other owners | 1928 |